MoneyWorks4Me

The March 2024 quarter revenue stood at Rs. 2199.38 millions, up 18.00% as compared to Rs. 1863.84 millions during the corresponding quarter last year.Modest increase of 18.12% in the Net Profit was reported from. 271.58 millions to Rs. 320.80  millions.Operating profit for the quarter ended March 2024 rose to 487.07 millions as compared to 406.44 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2199.38 1863.84 18.00 6875.83 6167.34 11.49 6875.83 6167.34 11.49
Other Income 85.54 -1.74 -5016.09 137.86 43.20 219.12 137.86 43.20 219.12
PBIDT 487.07 406.44 19.84 1214.53 1269.82 -4.35 1214.53 1269.82 -4.35
Interest 20.56 5.94 246.13 58.94 24.14 144.16 58.94 24.14 144.16
PBDT 466.51 400.50 16.48 838.05 1245.68 -32.72 838.05 1245.68 -32.72
Depreciation 43.63 34.27 27.31 146.94 123.42 19.06 146.94 123.42 19.06
PBT 422.88 366.23 15.47 691.11 1122.26 -38.42 691.11 1122.26 -38.42
TAX 102.08 94.65 7.85 254.25 288.82 -11.97 254.25 288.82 -11.97
Deferred Tax 29.02 5.96 386.91 45.12 25.05 80.12 45.12 25.05 80.12
PAT 320.80 271.58 18.12 436.86 833.44 -47.58 436.86 833.44 -47.58
Equity 368.81 364.37 1.22 368.81 364.37 1.22 368.81 364.37 1.22
PBIDTM(%) 22.15 21.81 1.56 17.66 20.59 -14.21 17.66 20.59 -14.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..